PRUDENTIAL FINANCIAL INC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$1,534,434
-44.4%
95,663
-19.6%
0.00%
-50.0%
Q2 2023$2,757,562
+17.9%
118,963
+18.2%
0.00%0.0%
Q1 2023$2,338,331
+54.9%
100,660
-3.2%
0.00%
+33.3%
Q4 2022$1,509,359
-28.2%
104,022
-5.5%
0.00%
-25.0%
Q3 2022$2,101,000
-4.6%
110,095
-9.1%
0.00%
+33.3%
Q2 2022$2,202,000
-22.5%
121,145
+7.4%
0.00%
-25.0%
Q1 2022$2,843,000
-54.3%
112,788
-50.0%
0.00%
-50.0%
Q4 2021$6,223,000
-45.4%
225,378
-36.2%
0.01%
-50.0%
Q3 2021$11,407,000
+8.5%
353,231
+2.8%
0.02%
+14.3%
Q2 2021$10,511,000
-20.2%
343,713
-20.5%
0.01%
-30.0%
Q1 2021$13,170,000
+118.0%
432,517
+41.6%
0.02%
+100.0%
Q4 2020$6,040,000
+405.4%
305,417
+233.2%
0.01%
+400.0%
Q3 2020$1,195,000
-15.2%
91,670
-26.2%
0.00%
-33.3%
Q2 2020$1,409,000
-16.1%
124,274
+5.9%
0.00%
-25.0%
Q1 2020$1,679,000
-47.4%
117,347
+0.0%
0.00%
-20.0%
Q4 2019$3,194,000
-5.0%
117,295
-0.1%
0.01%0.0%
Q3 2019$3,363,000
-58.3%
117,466
-59.6%
0.01%
-61.5%
Q2 2019$8,068,000
-34.1%
290,435
-21.2%
0.01%
-35.0%
Q1 2019$12,234,000
+1.5%
368,504
-11.1%
0.02%
-4.8%
Q4 2018$12,054,000
-56.8%
414,671
-31.6%
0.02%
-48.8%
Q3 2018$27,899,000
+109.6%
606,490
+70.3%
0.04%
+105.0%
Q2 2018$13,308,000
+190.0%
356,103
+129.3%
0.02%
+185.7%
Q1 2018$4,589,000
-0.8%
155,299
+15.3%
0.01%
+16.7%
Q4 2017$4,626,000
-2.4%
134,709
+2.8%
0.01%
-14.3%
Q3 2017$4,742,000
+45.4%
131,073
+3.9%
0.01%
+40.0%
Q2 2017$3,261,000
-15.3%
126,173
-37.0%
0.01%
-16.7%
Q1 2017$3,848,000
+1031.8%
200,423
+884.7%
0.01%
+500.0%
Q4 2016$340,000
-88.7%
20,353
-86.1%
0.00%
-80.0%
Q3 2016$3,005,000
-26.8%
146,033
+8.9%
0.01%
-28.6%
Q2 2016$4,103,000
-4.6%
134,083
+16.7%
0.01%
-12.5%
Q1 2016$4,300,000
+1463.6%
114,883
+1699.8%
0.01%
Q4 2015$275,000
+13.2%
6,383
-1.5%
0.00%
Q3 2015$243,000
+12.0%
6,483
+1.6%
0.00%
Q2 2015$217,000
+4.3%
6,383
+18.1%
0.00%
Q3 2014$208,000
-45.7%
5,404
-45.1%
0.00%
-100.0%
Q2 2014$383,000
-82.8%
9,835
-90.7%
0.00%
-75.0%
Q4 2013$2,229,000
-52.7%
106,254
-47.0%
0.00%
-60.0%
Q3 2013$4,713,000
-51.2%
200,554
-44.2%
0.01%
-52.4%
Q2 2013$9,661,000359,5540.02%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Camber Capital Management LP 6,635,000$106,4253.51%
Glenview Capital Management 3,783,982$60,695,0711.37%
AMH Equity Ltd 47,285$758,4510.83%
DISCIPLINED GROWTH INVESTORS INC /MN 1,973,312$31,651,9240.75%
EARNEST PARTNERS LLC 3,473,281$55,711,4270.32%
AIMZ Investment Advisors, LLC 40,985$657,3990.29%
PEREGRINE CAPITAL MANAGEMENT LLC 280,767$4,503,5030.13%
Beverly Hills Private Wealth, LLC 19,687$315,7790.09%
Artisan Partners Limited Partnership 2,537,147$40,695,8380.07%
Jump Financial, LLC 84,924$1,362,1810.05%
View complete list of MYRIAD GENETICS INC shareholders